Comparison Overview
AbbVie

AbbVie
1 Waukegan Road, North Chicago, 60064, US
Last Update: 10/09/2026
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, ...

Astellas Pharma
N/A
Last Update: 24/09/2026
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and develo...
Compliance Ranges Comparison

AbbVie







Astellas Pharma






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
AbbVie has 30.56% fewer incidents than the average of same-industry companies with at least one recorded incident.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Astellas Pharma in 2026.
Incident History - AbbVie (X = Date, Y = Severity)
AbbVie cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Astellas Pharma (X = Date, Y = Severity)
Astellas Pharma cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

AbbVie

Astellas Pharma
FAQ
Latest Global CVEs
A vulnerability was detected in mathurvishal CloudClassroom-PHP-Project up to 5dadec098bfbbf3300d60c3494db3fb95b66e7be. This impacts an unknown function of the file viewresult.php. Performing a manipulation of the argument seno results in sql injection. Remote exploitation of the attack is possible. The exploit is now public and may be used. This product follows a rolling release approach for continuous delivery, so version details for affected or updated releases are not provided. The vendor was contacted early about this disclosure but did not respond in any way.
Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)
Uncontrolled Resource Consumption (CWE-400) in Kibana can lead denial of service via Excessive Allocation (CAPEC-130)
Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)
Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)